Press Release Date: 

PHILADELPHIA, Sept. 27 /PRNewswire/ -- Chronic use of opiate drugs may alter brain neurons to make animal brains more sensitive to stress, according to a new study. If the research proves applicable to humans, the findings may
help explain how hospital patients who have received morphine may be
susceptible to stress disorder, attention problems and sleep disturbances.

The effects on the brain may also contribute to better understanding of
drug addiction.

The study, published in the September 22 issue of the "Journal of Neuroscience," was the first to show that chronic opiate use disrupts the stress response of nerve cells in the noradrenergic system. This system, using a neurotransmitter called norepinephrine, influences the brain's arousal and attention levels when a stressful event occurs.

The researchers observed that the norepinephrine neurons of rats that had
received morphine infusions for a week discharged more frequently in response
to a stressor, compared to neurons of rats that had not received morphine.
"The increase in neuron firing indicated the neurons were more sensitive to stress, and we also found this sensitization translated into behavioral
changes -- as shown in the rats' swimming behavior," said study leader Rita J. Valentino, Ph.D., a behavioral neuroscientist at The Children's Hospital of Philadelphia.

The researchers used a swim stress test that involved placing rats into glass containers of water. The opiate-treated rats tried to climb the chamber walls, in contrast to untreated rats, which exerted only the effort needed to float. "The climbing behavior reflected a higher activity level in the rats whose brains had been sensitized by the opiates," added Dr. Valentino.

In both humans and rats, a stressful event, such as blood loss, causes one
part of the brain to release a hormone called corticotropin-releasing factor
(CRF). CRF in turn stimulates neurons in a portion of the brain called the locus ceruleus. Cells in the locus release the neurotransmitter norepinephrine, which activates the area of the brain governing arousal responses (part of the "fight or flight" response to an attack).

The current study found that chronic exposure to the opiate drug morphine
made locus ceruleus neurons more sensitive to CRF than they had been
previously. If this process occurs similarly in humans, it could have practical implications for hospital patients receiving morphine or similar opiate drugs. "Based on these findings, we would predict that patients will have an increased sensitivity to stress," said Dr. Valentino. Jittery
patients might suffer disrupted sleep patterns, increased anxiety and other
symptoms, many of them similar to those found in people with post-traumatic
stress disorder (PTSD).

Researchers have previously noted sleep disturbances and a higher incidence of PTSD symptoms among opiate users, added Dr. Valentino. Her current study suggests that the opiate-induced sensitivity to stress may play a role in the cycle of addiction that causes drug abusers to continue seeking drugs. However, she added, the role of the norepinephrine system in opiate-
seeking behavior remains controversial, and further studies are needed.

As a practical matter, physicians and family members of patients who are
taking opiates should be aware of the potential for increased stress symptoms,
explained Dr. Valentino. Both children and adults may receive opiates as painkillers in the hospital, and one concern is that young children are
particularly vulnerable to the effects of stress because their brains are developing. "As research advances in this field, we may be able to find other
opiate medications that do not sensitize neurons to the same degree," she

Dr. Valentino's co-authors on this study were Guang-Ping Xu and Thelma Bethea, also of The Children's Hospital of Philadelphia, and Elisabeth Van Bockstaele, Ph.D., and Beverly Reyes, of Jefferson Medical College of Thomas
Jefferson University. Support for the study came from The National Institute
of Drug Abuse and the National Institute of Mental Health, along with the National Alliance for Research on Schizophrenia and Depression.

Founded in 1855 as the nation's first pediatric hospital, The Children's Hospital of Philadelphia is ranked today as the best pediatric hospital in the nation by U.S.News & World Report and Child magazine. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking second in National Institutes of Health funding. In addition, its unique family-centered care and public service
programs have brought the 430-bed hospital recognition as a leading advocate
for children and adolescents from before birth through age 19. For more information, visit

Contact: John Ascenzi
(267) 426-6055